MENU
MRK
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Merck & Co (MRK) Earnings Date & Reports

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

A.I. Advisor
published Earnings

MRK is expected to report earnings to fall 19.38% to $2.08 per share on February 03

Merck & Co MRK Stock Earnings Reports
Q4'25
Est.
$2.08
Q3'25
Beat
by $0.23
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.09
The last earnings report on October 30 showed earnings per share of $2.58, beating the estimate of $2.35. With 6.17M shares outstanding, the current market capitalization sits at 226.98B.
View a ticker or compare two or three
MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MRK showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
72000
Web
https://www.merck.com